ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AZN Astrazeneca Plc

12,050.00
-106.00 (-0.87%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -106.00 -0.87% 12,050.00 12,036.00 12,038.00 12,178.00 12,010.00 12,092.00 1,635,146 16:35:23
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 45.81B 5.96B 3.8415 31.34 186.61B

Canada Clinches Covid-19 Vaccine Deal With Serum Institute of India

26/02/2021 6:00pm

Dow Jones News


Astrazeneca (LSE:AZN)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Astrazeneca Charts.
   By Paul Vieira 
 

OTTAWA--Canada said Friday it secured a deal with the Serum Institute of India to acquire two million doses of the organization's version of the Covid-19 vaccine produced by AstraZeneca PLC in partnership with Oxford University.

News of the deal emerged hours after Canada authorized use of AstraZeneca's Covid-19 vaccine, as well as the version produced by the Serum Institute, which is the world's largest maker of vaccines. Canada said on Feb. 12 it was in talks with the Serum Institute, which makes more than a billion doses a year for everything from polio to measles, mostly for export to emerging markets.

Canada said in a statement the first 500,000 doses from the Serum Institute will be delivered to Canada in the coming weeks for distribution to the provinces and territories, which are in charge of the inoculation process. The remaining 1.5 million doses will arrive by mid-May.

The Canadian government has agreed to purchase 20 million doses of the AstraZeneca-Oxford vaccine. AstraZeneca said in a statement it is working with Canadian officials to deliver doses as quickly as possible.

 

Write to Paul Vieira at paul.vieira@wsj.com

 

(END) Dow Jones Newswires

February 26, 2021 12:45 ET (17:45 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

1 Year Astrazeneca Chart

1 Year Astrazeneca Chart

1 Month Astrazeneca Chart

1 Month Astrazeneca Chart

Your Recent History

Delayed Upgrade Clock